These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2510280)

  • 1. Pharmacokinetics of rioprostil in rats.
    Petersen-von Gehr JK; Siefert HM; Steinke W
    Scand J Gastroenterol Suppl; 1989; 164():46-50; discussion 50-1. PubMed ID: 2510280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of rioprostil in human plasma as assayed by combined capillary gas chromatography-negative ion chemical ionization mass spectrometry.
    Fischer S; Schweer H; Kraft H; Weber P
    Scand J Gastroenterol Suppl; 1989; 164():59-61; discussion 61-2. PubMed ID: 2510282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of rioprostil in the rat--in vivo and in liver perfusion.
    Ahr HJ; Karl W; Scherling D; Wünsche C
    Scand J Gastroenterol Suppl; 1989; 164():52-7. PubMed ID: 2510281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interactions between theophylline and rioprostil.
    de Lauture D; Rey E; d'Athis P; Richard MO; Paccaly D; Prunieras F; Strauch G; Olive G
    Scand J Gastroenterol Suppl; 1989; 164():63-6; discussion 67. PubMed ID: 2510283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analog.
    Katz LB; Genna T; Scott CK; Rosenthale ME; Shriver DA
    Life Sci; 1987 Sep; 41(13):1591-8. PubMed ID: 3114582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rioprostil, a methyl-prostaglandin E1, on plasma level and renal excretion of beta-acetyldigoxin.
    Demol P; Wingender W; Kuhlmann J
    Scand J Gastroenterol Suppl; 1989; 164():68-71; discussion 71-2. PubMed ID: 2510284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rioprostil, a new prostaglandin E1, prevents cyclosporin A-induced damage to endocrine and exocrine pancreas.
    Müller M; Degenhardt H; Bergmann K; Coone H; Löhr M; Klöppel G; Goebell H
    Scand J Gastroenterol Suppl; 1989; 164():35-41. PubMed ID: 2510278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of chronic rioprostil treatment on gastric endocrine function.
    Koop H; Schwarting H; Eckel U; Wagenknecht J; Hallfeldt U; Arnold R
    Scand J Gastroenterol Suppl; 1989; 164():104-10; discussion 110-1. PubMed ID: 2573147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rioprostil and the gastric mucus-bicarbonate barrier.
    Guslandi M; Fasani R; Tittobello A
    Scand J Gastroenterol Suppl; 1989; 164():92-5; discussion 95-6. PubMed ID: 2510287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
    Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
    J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of the prostaglandin E derivative rioprostil with oral anticoagulant agents.
    Thijssen HH; Hamulyàk K
    Clin Pharmacol Ther; 1989 Jul; 46(1):110-6. PubMed ID: 2501056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 164():133-8; discussion 138-9. PubMed ID: 2510257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric antisecretory and antigastrolesive pharmacology of rioprostil.
    Shriver DA; Katz LB; Rosenthale ME
    Scand J Gastroenterol Suppl; 1989; 164():10-20. PubMed ID: 2510252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of rioprostil with the parietal cell prostaglandin E2 receptor.
    Beinborn M; Nüstedt V; Sewing KF
    Scand J Gastroenterol Suppl; 1989; 164():21-4; discussion 24-5. PubMed ID: 2554487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rioprostil on oesophageal motility.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 164():118-9. PubMed ID: 2510254
    [No Abstract]   [Full Text] [Related]  

  • 16. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers.
    Cohen A; Tolman KG; Lewis GP; Brown S; van Horn A; McCormack GH; Simon DM
    Scand J Gastroenterol Suppl; 1989; 164():81-90; discussion 90-1. PubMed ID: 2510286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single evening dose of rioprostil, 600 micrograms, in the treatment of acute duodenal ulcers.
    Dammann HG; Dreyer M; Müller P; Simon B; Demol P
    Scand J Gastroenterol Suppl; 1989; 164():215-8. PubMed ID: 2510271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rioprostil, a methylprostaglandin E1 analog, on basal and stimulated plasma pancreatic hormone levels in man.
    Segers O; Somers G
    Dig Dis Sci; 1990 Jan; 35(1):20-6. PubMed ID: 2104796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and physiological effects of a cytoprotective prostaglandin analog (rioprostil) on the rat gastric mucosa.
    Morris GP; Keenan CM; Shriver DA
    Clin Invest Med; 1987 May; 10(3):121-31. PubMed ID: 3113797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
    Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
    Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.